Free Trial

Greater Cannabis (GCAN) Competitors

Greater Cannabis logo
$0.0010 0.00 (-9.09%)
As of 02:36 PM Eastern

GCAN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying Greater Cannabis stock or one of its competitors? The main competitors of Greater Cannabis include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Greater Cannabis vs.

Greater Cannabis (NASDAQ:GCAN) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.

Greater Cannabis received 10 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
Greater CannabisOutperform Votes
10
76.92%
Underperform Votes
3
23.08%
180 Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
Greater CannabisN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greater CannabisN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Greater Cannabis' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Greater Cannabis Neutral
180 Life Sciences Neutral

Summary

Greater Cannabis beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Greater Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for GCAN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GCAN vs. The Competition

MetricGreater CannabisDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.18B$5.43B$7.80B
Dividend YieldN/A2.92%5.44%4.31%
P/E RatioN/A4.3722.2418.35
Price / SalesN/A499.23389.36100.72
Price / CashN/A10.2538.2034.62
Price / BookN/A6.386.654.17
Net IncomeN/A$20.70B$3.21B$247.71M
7 Day PerformanceN/A2.61%5.49%6.17%
1 Month PerformanceN/A-1.01%-4.63%-3.37%
1 Year PerformanceN/A93.30%17.67%5.25%

Greater Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GCAN
Greater Cannabis
N/A$0.00
-9.1%
N/A+57.1%$0.00N/A0.001Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-2.5%
N/A-7.2%$0.00N/A0.007Positive News
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
-15.8%
N/A-69.6%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.09
+10.4%
N/AN/A$0.00$20,729.000.0040Positive News
ALVOW
Alvotech
N/A$1.30
-13.9%
N/A-56.8%$0.00$489.68M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.07
+7.7%
N/A-16.5%$0.00$37.32M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.03
+17.0%
N/A-89.8%$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.08
-15.8%
N/A-81.0%$0.00N/A0.008Positive News
Gap Down
CALA
Calithera Biosciences
N/A$0.00
-90.0%
N/A-82.8%$0.00N/A0.0060Analyst Forecast

Related Companies and Tools


This page (NASDAQ:GCAN) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners